We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rtw Biotech Opportunities Ltd | LSE:RTWG | London | Ordinary Share | GG00BKTRRM22 | ORD NPV (GBP) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 107.00 | 104.00 | 110.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 4.17M | -4.76M | -0.0226 | -59.29 | 282.25M |
TIDMRTW
RNS Number : 0215V
RTW Venture Fund Limited
31 March 2023
RTW VENTURE FUND LIMITED
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name William Scott ------------------------- ----------------------------------------- 2 Reason for the notification -------------------------------------------------------------------- a) Position/status Director of RTW Venture Fund Limited ------------------------- ----------------------------------------- b) Initial notification Initial notification /Amendment ------------------------- ----------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor -------------------------------------------------------------------- a) Name RTW Venture Fund Limited ------------------------- ----------------------------------------- b) LEI 549300Q7EXQQH6KF7Z84 ------------------------- ----------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted -------------------------------------------------------------------- a) Description Ordinary shares of no par value of the financial instrument, type of instrument Identification GG00BKTRRM22 code ------------------------- ----------------------------------------- b) Nature of Purchase of Shares the transaction ------------------------- ----------------------------------------- c) Price(s) and Price(s) Volume(s) volume(s) $1.025022 44,997 ---------- ------------------------- ----------------------------------------- Aggregated information - Aggregated 44,997 volume d) - Price $1.025022 ------------------------- ----------------------------------------- e) Date of the 31 March 2023 transaction ------------------------- ----------------------------------------- f) Place of the London Stock Exchange transaction ------------------------- -----------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBLGDXIBXDGXB
(END) Dow Jones Newswires
March 31, 2023 12:20 ET (16:20 GMT)
1 Year Rtw Biotech Opportunities Chart |
1 Month Rtw Biotech Opportunities Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions